Analysts Set Expectations for Gilead Sciences Q1 Earnings

Analysts Set Expectations for Gilead Sciences Q1 Earnings

Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) - Analysts at Zacks Research upped their Q1 2027 EPS estimates for Gilead Sciences in a research note issued on Thursday, March 12th. Zacks Research analyst Team now expects that the biopharmaceutical company will post earnings of $2.07 per share for

Why Ur-Energy Stock Was Rising This Week

Key PointsIt appears its main asset has much more potential than previously assumed.This mitigated a yearly financial update that showed a top-line decline and a deeper net loss.10 stocks we like better than Ur-Energy › Investors have been rather energized about Ur-Energy (NYSEMKT: URG) lately. That's due in part to greater visibility, as the uranium production and exploration company specializes in a material used for power generation that isn'…